The forecasted use of cardiovascular system medicine in the UK from 2024 to 2028 shows a steady increase in Units (Defined Daily Dosage) per Thousand Persons per Day. Specifically, the data indicates values of 574.4 in 2024, rising incrementally to 580.4 by 2028. This smooth upward trend underlines a consistent demand for cardiovascular medications over the forecasted period. Examining the year-on-year variation, the increase remains modest, with minor percentage changes that reinforce the trend's stability. From 2023's actual usage of 572, the cumulative average growth rate (CAGR) over the five years accounts for a consistent growth trajectory.
Future trends to watch for:
- Technological advancements in cardiovascular treatments, which may influence usage rates.
- Changes in population demographics, particularly aging populations, potentially heightening demand.
- Healthcare policy reforms that could impact accessibility and affordability of cardiovascular medications.
